No Recent News for the Company
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 To Be Held On Tuesday June 09 2026.
02-Jun-2026 | Source : BSEGoldline Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2026 inter alia to consider and approve Standalone Audited financials results for the half year and year ended 31st March 2026.
Listing of Equity Shares of Goldline Pharmaceutical Ltd
19-May-2026 | Source : BSETrading Members of the Exchange are hereby informed that effective from May 19 2026 the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260518- dated May 18 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






